Dr Rafał Kamiński has a broad international experience in discovery and development of innovative small molecule drugs. After obtaining medical degree and doctorate in pharmacology at the Medical University of Lublin (Poland), he completed his post-doctoral training in the Netherlands (Radboud University) and USA (National Institutes of Health), as well as obtained the Diploma in Pharmaceutical Medicine (ULB, Belgium). He joined pharmaceutical industry more than 12 years ago and worked for UCB Pharma (Belgium) and Roche (Switzerland). In both companies he has led R&D teams, where he was responsible for strategy, portfolio of preclinical projects and selection of clinical candidates. Two of his projects successfully completed Phase I/II studies and one drug candidate is currently in Phase III clinical development. He also has experience in coordination and oversight of drug discovery projects performed in collaboration with external partners (CRO, biotech). He was a member of scientific advisory boards and expert committees (FP7 UE; Wellcome Trust). Dr Kamiński authored more than 80 scientific papers (including Nature group journals) and his publications were cited more than 2500 times (Google Scholar). He is also an inventor or co-inventor in 6 patent applications.